| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| Cost of Revenue | $0 | — |
| Gross Profit | $0 | — |
| R&D Expense | $262K | -46.7% |
| Operating Income | -$1.4M | +15.1% |
| Pre-tax Income | -$1.4M | +67.0% |
| Income Tax | $0 | — |
| Net Income | -$1.4M | +67.0% |
| EPS (Basic) | $0.00 | +100.0% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12K | -89.1% |
| Short-term Investments | $0 | — |
| Current Assets | $103K | -66.6% |
| Total Assets | $103K | -70.6% |
| Current Liabilities | $5.1M | +7.1% |
| Total Liabilities | $5.4M | +13.8% |
| Stockholders' Equity | -$5.3M | -20.6% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$976K | +36.1% |
| Investing Cash Flow | $320K | +1111.1% |
| Financing Cash Flow | $558K | -61.1% |